is one of the major tools used in cellular and molecular biology, delivering excellent model systems for studying the normal physiology and biochemistry of cells the effects of drugs and toxic compounds on the cells, and mutagenesis and carcinogenesis. It is also used in drug screening and development, and large scale production of biological compounds. The major advantage of using cell culture for any of these applications is the consistency and reproducibility of results that can be obtained from using a batch of clonal cells. The global cell culture market
is mainly categorized into products, type, application, end user and by geography. The key products of cell culture consumables are media, sera and reagent.
The global cell culture market has grown significantly in the last ten years. The demand for artificial organs and biopharmaceuticals has boosted this market extensively in past and is likely to fuel its growth further in the coming years. Additionally, the rising usage of cell culture models in drug discoveries is expected to present an opportunity-rich market for major cell culture market players.
The global market for cell culture was assessed to be $xx bn in 2016. The cell culture market is projected to grow at a CAGR of xx% and is forecast to reach $xx bn by 2021. The 3D cell culture is forecast to have the maximum growth of xx% during the forecast period between 2016 and 2021. Cancer research laboratories and pharmaceutical companies are the major end-users for cell culture. North America and Europe alone are estimated to occupy a share of more than xx% during 2016-2021.
Europe is the leading market for cell culture with Germany being the frontrunner. Europe region is forecast to have highest growth in the next few years due to growing adoption of cell culture in industrial applications. Europe cell culture market accounts to xx% of the global market for cell culture and is the fastest growing market followed by Americas. In Americas, Biopharmaceuticals and University research institutes are the major end users of cell culture.